posted on 2021-01-12, 17:26authored byPJ Highton, M Hadjiconstantinou, S Schreder, S Seidu, M Davies, K Khunti
Cardiometabolic diseases (e.g. cardiovascular disease, diabetes, hypertension, chronic kidney disease) are the most prevalent chronic conditions globally and often co-occur (termed cardiometabolic multimorbidity), driving mortality [1]. Recent evidence highlights that pre-existing cardiometabolic comorbidities and poorly controlled cardiovascular risk factors are associated with adverse clinical outcomes among COVID-19 patients [2]. [Taken from opening paragraph]